With the support of the international community, Nigeria and other countries affected by Africa's deadliest mpox surge on record are able to administer vaccines against the disease — at least to specific groups — and control the epidemic. There's still a long way to go, but the future looks much brighter now than during the 2022 outbreak.
Despite the WHO having twice raised the alarm internationally over the threat posed by mpox, not enough has been done to tackle this crisis. Some have even blamed "vaccine nationalism" — the inequity by which nations exploit their relative wealth to reserve vaccines in advance of their availability to the developing world — undermining the efficacy of any potential global response. Even the current vaccine rollout is limited to only the highest risk groups, rather than the broader population.